Cargando…
Identification of NUDT5 Inhibitors From Approved Drugs
Recent studies have revealed the important role of NUDT5 in estrogen signaling and breast cancer, but research on the corresponding targeted therapy has just started. Drug repositioning strategy can effectively reduce the time and economic resources spent on drug discovery. To find novel inhibitors...
Autores principales: | Tong, Xin-Yu, Liao, Xuan, Gao, Min, Lv, Bo-Min, Chen, Xiao-Hui, Chu, Xin-Yi, Zhang, Qing-Ye, Zhang, Hong-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145388/ https://www.ncbi.nlm.nih.gov/pubmed/32300600 http://dx.doi.org/10.3389/fmolb.2020.00044 |
Ejemplares similares
-
Molecular mechanisms of histone deacetylases and inhibitors in renal fibrosis progression
por: Wang, Jiayu, et al.
Publicado: (2022) -
Identification of immune-related ferroptosis prognostic marker and in-depth bioinformatics exploration of multi-omics mechanisms in thyroid cancer
por: Fan, Xin, et al.
Publicado: (2022) -
Identification of Key Genes in Lung Adenocarcinoma and Establishment of Prognostic Mode
por: Jiawei, Zhou, et al.
Publicado: (2020) -
SPARC: a potential target for functional nanomaterials and drugs
por: Jiang, Shan, et al.
Publicado: (2023) -
Identification of Tamoxifen-Resistant Breast Cancer Cell Lines and Drug Response Signature
por: Guan, Qingzhou, et al.
Publicado: (2020)